Aptalis Pharma Overview
- Year Founded
-
1982
- Status
-
Acquired/Merged
- Employees
-
1,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
15
- Investments
-
6
Aptalis Pharma General Information
Description
Manufacturer of pharmaceutical products intended for the treatment of gastrointestinal diseases. The company offers therapies for cystic fibrosis and gastrointestinal disorders, as well as pharmaceutical products for exocrine pancreatic insufficiency, enabling patients to get proper medication for their health problems conveniently.
Contact Information
Website
www.aptalispharma.comCorporate Office
- 100 Somerset Corporate Boulevard
- Suite 2000
- Bridgewater, NJ 08807
- United States
Corporate Office
- 100 Somerset Corporate Boulevard
- Suite 2000
- Bridgewater, NJ 08807
- United States
Aptalis Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aptalis Pharma Comparisons
Industry
Financing
Details
Aptalis Pharma Competitors (85)
One of Aptalis Pharma’s 85 competitors is The Zambon Group, a Private Debt Financed company based in Bresso, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy | ||||
| Evoke Pharma | Formerly VC-backed | Solana Beach, CA | ||||
| Mirum Pharmaceuticals | Formerly VC-backed | Foster City, CA |
Aptalis Pharma Signals
Aptalis Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Aptalis Pharma Investments & Acquisitions (6)
Aptalis Pharma’s most recent deal was a Buyout/LBO with Mpex Pharmaceuticals for . The deal was made on 01-Jul-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mpex Pharmaceuticals | 01-Jul-2011 | Buyout/LBO | Pharmaceuticals | ||
| Eurand | 11-Feb-2011 | Buyout/LBO | Pharmaceuticals | ||
| Laboratoires Enteris | 07-Nov-2001 | Merger/Acquisition | Distributors (Healthcare) | ||
| Scandipharm | 10-Sep-1999 | Merger/Acquisition | Pharmaceuticals | ||
| Bonne Sante | 31-Aug-1999 | Merger/Acquisition | Consulting Services (B2B) |
Aptalis Pharma Exits (2)
Aptalis Pharma’s most recent exit was on 31-Aug-1999 from Bonne Sante. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Bonne Sante | 31-Aug-1999 | Completed |
|
||
| Althin Biopharm | 19-Dec-1995 | Joint Venture | Completed |
|
Aptalis Pharma FAQs
-
When was Aptalis Pharma founded?
Aptalis Pharma was founded in 1982.
-
Where is Aptalis Pharma headquartered?
Aptalis Pharma is headquartered in Bridgewater, NJ.
-
What is the size of Aptalis Pharma?
Aptalis Pharma has 1,000 total employees.
-
What industry is Aptalis Pharma in?
Aptalis Pharma’s primary industry is Pharmaceuticals.
-
Is Aptalis Pharma a private or public company?
Aptalis Pharma is a Private company.
-
What is the current valuation of Aptalis Pharma?
The current valuation of Aptalis Pharma is .
-
What is Aptalis Pharma’s current revenue?
The current revenue for Aptalis Pharma is .
-
How much funding has Aptalis Pharma raised over time?
Aptalis Pharma has raised $1.12B.
-
Who are Aptalis Pharma’s investors?
Aisling Capital, Alberta Investment Management, Fonds de solidarite FTQ, Graycliff Partners, and La Caisse are 5 of 13 investors who have invested in Aptalis Pharma.
-
Who are Aptalis Pharma’s competitors?
The Zambon Group, Dicerna Pharmaceuticals, Chiesi Farmaceutici, Evoke Pharma, and Mirum Pharmaceuticals are some of the 85 competitors of Aptalis Pharma.
-
When was Aptalis Pharma acquired?
Aptalis Pharma was acquired on 06-Feb-2014.
-
Who acquired Aptalis Pharma?
Aptalis Pharma was acquired by Forest Laboratories.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process